|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...4445464748495051525354...110111» |
- Trial primary completion date: Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva (clinicaltrials.gov) - Jun 11, 2015
P3, N=515, Completed, Sponsor: Gynecologic Oncology Group
Trial primary completion date: Mar 2010 --> Jul 2013
- | Trial termination: Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause (clinicaltrials.gov) - Jun 11, 2015
P3, N=126, Terminated, Sponsor: University of Erlangen-N
Trial primary completion date: Mar 2010 --> Jul 2013 Completed --> Terminated
- Trial termination, Trial primary completion date: Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=102, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated | Trial primary completion date: Dec 2010 --> Jan 2013
- | buparlisib (AN2025) / Novartis, Adlai Nortye
Trial initiation date, Metastases: Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer (clinicaltrials.gov) - Jun 11, 2015
P2, N=27, Not yet recruiting, Sponsor: Novartis Pharmaceuticals
Completed --> Terminated | Trial primary completion date: Dec 2010 --> Jan 2013 Initiation date: Jul 2015 --> Feb 2016
- Trial initiation date, Trial primary completion date, HEOR: Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=2605, Not yet recruiting, Sponsor: Gynecologic Oncology Group
Initiation date: Jul 2015 --> Feb 2016 Initiation date: Oct 2012 --> Jan 2100 | Trial primary completion date: Oct 2013 --> Jan 2100
- Biomarker, Trial initiation date, Trial primary completion date: Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=360, Not yet recruiting, Sponsor: Gynecologic Oncology Group
Initiation date: Oct 2012 --> Jan 2100 | Trial primary completion date: Oct 2013 --> Jan 2100 Initiation date: Apr 2011 --> Jan 2100 | Trial primary completion date: May 2011 --> Jan 2100
- Biomarker, Trial initiation date, Trial primary completion date: Prognostic Biomarkers in Patients With Endometrial Cancer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=2824, Not yet recruiting, Sponsor: Gynecologic Oncology Group
Initiation date: Apr 2011 --> Jan 2100 | Trial primary completion date: May 2011 --> Jan 2100 Initiation date: Oct 2010 --> Jan 2100 | Trial primary completion date: Nov 2010 --> Jan 2100
- Biomarker, Trial initiation date, Trial primary completion date: Biomarkers in Samples From Patients With Endometrial Cancer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=3600, Not yet recruiting, Sponsor: Gynecologic Oncology Group
Initiation date: Oct 2010 --> Jan 2100 | Trial primary completion date: Nov 2010 --> Jan 2100 Initiation date: Oct 2010 --> Jan 2100 | Trial primary completion date: Nov 2010 --> Jan 2100
- Biomarker, Trial initiation date, Trial primary completion date: Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=243, Not yet recruiting, Sponsor: Gynecologic Oncology Group
Initiation date: Oct 2010 --> Jan 2100 | Trial primary completion date: Nov 2010 --> Jan 2100 Initiation date: Oct 2010 --> Jan 2100 | Trial primary completion date: Nov 2010 --> Jan 2100
- ||||| Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Trial initiation date: Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED) (clinicaltrials.gov) - Jun 11, 2015
P3, N=1877, Completed, Sponsor: Merck Sharp & Dohme Corp.
Initiation date: Oct 2010 --> Jan 2100 | Trial primary completion date: Nov 2010 --> Jan 2100 Initiation date: Mar 2003 --> Dec 2001
- Neulasta (pegfilgrastim) / Roche
New P2 trial, Metastases: Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta (clinicaltrials.gov) - Jun 11, 2015
P2, N=18, Terminated, Sponsor: Washington University School of Medicine
- Trial completion, Trial primary completion date: Study of Vaginal Dilator Use After Pelvic Radiotherapy (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=115, Completed, Sponsor: Memorial Sloan Kettering Cancer Center
Initiation date: Mar 2003 --> Dec 2001 Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Jun 2015
- New trial: EnMotion, Embryo's Natural Motion (clinicaltrials.gov) - Jun 10, 2015
P=N/A, N=200, Recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
- || New P2/3 trial: Multi-factorial Analysis of the Follicular Fluid Milieu to Explore the Discrepant Effect of Follicular Fluid Endometrial Flushing on Outcome of Assisted Reproduction Trial (clinicaltrials.gov) - Jun 10, 2015
P2/3, N=80, Recruiting, Sponsor: Benha University
- | veliparib (ABT-888) / AbbVie
Trial completion, Enrollment change, BRCA Biomarker: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status (clinicaltrials.gov) - Jun 10, 2015
P1/2, N=22, Completed, Sponsor: Vejle Hospital
Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Jun 2015 Active, not recruiting --> Completed | N=80 --> 22
- New trial: TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors (clinicaltrials.gov) - Jun 9, 2015
P=N/A, N=300, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center
- | Elonva (corifollitropin alfa) / Organon
New P4 trial, Preclinical: Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients (clinicaltrials.gov) - Jun 9, 2015
P4, N=400, Enrolling by invitation, Sponsor: Vietnam National University
- Trial completion, Trial primary completion date: Embryo Development Using Two Commercial Single-step Media (clinicaltrials.gov) - Jun 9, 2015
P=N/A, N=43, Completed, Sponsor: Eugonia
Active, not recruiting --> Completed | N=80 --> 22 Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jun 2015
- ||| New trial: Pillars4Life Trial (clinicaltrials.gov) - Jun 9, 2015
P=N/A, N=180, Recruiting, Sponsor: Duke University
- Trial completion, Trial primary completion date: 2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial (clinicaltrials.gov) - Jun 8, 2015
P=N/A, N=36, Completed, Sponsor: Catholic University of the Sacred Heart
Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jun 2015 Recruiting --> Completed | Trial primary completion date: Oct 2016 --> Mar 2015
- Trial completion, Trial primary completion date, Metastases: 2D Versus 3D Radical Laparoscopic Hysterectomy for Cervical Cancer: a Prospective Randomized Trial (clinicaltrials.gov) - Jun 8, 2015
P=N/A, N=26, Completed, Sponsor: Catholic University of the Sacred Heart
Recruiting --> Completed | Trial primary completion date: Oct 2016 --> Mar 2015 Recruiting --> Completed | Trial primary completion date: Oct 2016 --> Mar 2015
- |||| Perjeta (pertuzumab) / Roche
Trial completion, Combination therapy: A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Jun 8, 2015
P2, N=131, Completed, Sponsor: Genentech, Inc.
Recruiting --> Completed | Trial primary completion date: Oct 2016 --> Mar 2015 No longer recruiting --> Completed
- |||| gepotidacin (GSK2140944) / GSK
Enrollment open: A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae (clinicaltrials.gov) - Jun 6, 2015
P2, N=100, Recruiting, Sponsor: GlaxoSmithKline
No longer recruiting --> Completed Not yet recruiting --> Recruiting
- Ovidrel (choriogonadotropin alfa) / EMD Serono
Trial completion, Enrollment change, Trial primary completion date: Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures (clinicaltrials.gov) - Jun 6, 2015
P4, N=3, Completed, Sponsor: Rambam Health Care Campus
Not yet recruiting --> Recruiting Recruiting --> Completed | N=100 --> 3 | Trial primary completion date: Jan 2016 --> Jan 2015
- Trial completion, Enrollment change, Trial primary completion date: IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing (clinicaltrials.gov) - Jun 6, 2015
P=N/A, N=11, Completed, Sponsor: Rambam Health Care Campus
Recruiting --> Completed | N=100 --> 3 | Trial primary completion date: Jan 2016 --> Jan 2015 Recruiting --> Completed | N=50 --> 11 | Trial primary completion date: Jan 2016 --> Nov 2014
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
Enrollment change, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - Jun 6, 2015
P1, N=12, Active, not recruiting, Sponsor: Case Comprehensive Cancer Center
Recruiting --> Completed | N=50 --> 11 | Trial primary completion date: Jan 2016 --> Nov 2014 N=20 --> 12
- buprenorphine transdermal / Generic mfg.
Trial completion, Trial primary completion date: Strength Training Study for Survivors of Breast and Gynecologic Cancer (clinicaltrials.gov) - Jun 6, 2015
P=N/A, N=20, Completed, Sponsor: Nova Scotia Health Authority
N=20 --> 12 Recruiting --> Completed | Trial primary completion date: May 2013 --> Jan 2015
- Trial completion, Preclinical: inSIGHT: SIGnificance of Routine Hysteroscopy Prior to a First 'in Vitro Fertilization'(IVF) Treatment Cycle (clinicaltrials.gov) - Jun 4, 2015
P4, N=750, Completed, Sponsor: UMC Utrecht
Recruiting --> Completed | Trial primary completion date: May 2013 --> Jan 2015 Active, not recruiting --> Completed
- ||| BAY 1128688 / Bayer
Enrollment open: Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy Women (clinicaltrials.gov) - Jun 4, 2015
P1, N=54, Recruiting, Sponsor: Bayer
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- New trial: STI/HIV Prevention Intervention for Adolescents in Singapore (clinicaltrials.gov) - Jun 3, 2015
P=N/A, N=700, Active, not recruiting, Sponsor: National University, Singapore
- Enrollment closed: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) (clinicaltrials.gov) - Jun 3, 2015
P2, N=250, Active, not recruiting, Sponsor: Harold Wiesenfeld
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | stenoparib (2X-121) / Allarity Therap, Oncoheroes
Enrollment closed, Enrollment change, Combination therapy, Metastases: An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Jun 3, 2015
P1/2, N=41, Active, not recruiting, Sponsor: Eisai Limited
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=198 --> 41
- Viracept (nelfinavir) / ViiV Healthcare, Roche
Trial completion, Enrollment change, Metastases: Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer (clinicaltrials.gov) - Jun 3, 2015
P1, N=8, Completed, Sponsor: University of Miami
Recruiting --> Active, not recruiting | N=198 --> 41 Active, not recruiting --> Completed | N=24 --> 8
- | New P4 trial: The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome (clinicaltrials.gov) - Jun 2, 2015
P4, N=93, Completed, Sponsor: Maimonides Medical Center
- | clomifene citrate / Generic mfg.
New P4 trial, Preclinical: IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS (clinicaltrials.gov) - Jun 1, 2015
P4, N=100, Not yet recruiting, Sponsor: Mohamed Sayed Abdelhafez
- ||||| Menopur (menotropin) / Ferring
New P4 trial, Preclinical: Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj. (clinicaltrials.gov) - Jun 1, 2015
P4, N=112, Completed, Sponsor: LG Life Sciences
- topotecan / Generic mfg.
Enrollment change: Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer (clinicaltrials.gov) - Jun 1, 2015
P2, N=27, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed | N=24 --> 8 N=60 --> 27
- Enrollment change, Trial withdrawal, Metastases: Research Study in Patients With Advanced Ovarian Epithelial Cancer (clinicaltrials.gov) - Jun 1, 2015
P=N/A, N=0, Withdrawn, Sponsor: Gynecologic Oncology Group
N=60 --> 27 N=158 --> 0 | Not yet recruiting --> Withdrawn
- birinapant (IGM-9427) / IGM Biosciences, conatumumab (AMG 655) / Amgen
Enrollment closed, Trial primary completion date, Combination therapy: Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer (clinicaltrials.gov) - Jun 1, 2015
P1, N=40, Active, not recruiting, Sponsor: TetraLogic Pharmaceuticals
N=158 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Aug 2015
- || Avastin (bevacizumab) / Roche
Enrollment closed, Combination therapy, Metastases: An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1) (clinicaltrials.gov) - Jun 1, 2015
P=N/A, N=303, Active, not recruiting, Sponsor: Hoffmann-La Roche
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Aug 2015 Recruiting --> Active, not recruiting
- motesanib (AMG 706) / Takeda
Trial completion, Enrollment change: AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (clinicaltrials.gov) - Jun 1, 2015
P2, N=23, Completed, Sponsor: Gynecologic Oncology Group
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | N=85 --> 23
- | topotecan / Generic mfg.
Trial completion: Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer (clinicaltrials.gov) - May 30, 2015
P2, N=27, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed | N=85 --> 23 Active, not recruiting --> Completed
- New trial, Preclinical: An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro (clinicaltrials.gov) - May 29, 2015
P=N/A, N=100, Recruiting, Sponsor: National Foundation for Fertility Research
- | clomifene citrate / Generic mfg.
New P4 trial, Preclinical: IVF Versus LOD in Women With CC Resistant PCOS (clinicaltrials.gov) - May 29, 2015
P4, N=100, Not yet recruiting, Sponsor: Mohamed Sayed Abdelhafez
- Enrollment status: Effect of Endometrial Scratching on Assisted Reproduction Outcomes: a Randomized Controlled Trial (clinicaltrials.gov) - May 29, 2015
P=N/A, N=600, Enrolling by invitation, Sponsor: University of Sao Paulo
Active, not recruiting --> Completed Recruiting --> Enrolling by invitation
- Enrollment open, Trial initiation date, Trial primary completion date: Endometrial Scratching for Cryopreserved Embryo Transfer (clinicaltrials.gov) - May 29, 2015
P=N/A, N=300, Enrolling by invitation, Sponsor: University of Sao Paulo
Recruiting --> Enrolling by invitation Withdrawn --> Enrolling by invitation | Initiation date: Jul 2013 --> Jul 2014 | Trial primary completion date: Aug 2013 --> Jul 2016
- Biomarker, Enrollment open, Surgery, Metastases: Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer (clinicaltrials.gov) - May 29, 2015
P=N/A, N=174, Recruiting, Sponsor: Gynecologic Oncology Group
Withdrawn --> Enrolling by invitation | Initiation date: Jul 2013 --> Jul 2014 | Trial primary completion date: Aug 2013 --> Jul 2016 Active, not recruiting --> Recruiting
- | New P4 trial: Lower Abdominal Pain During Office Hysteroscopy Can Assess Tubal Patency in Infertile Women (clinicaltrials.gov) - May 28, 2015
P4, N=60, Recruiting, Sponsor: Cairo University
- Enrollment open: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - May 28, 2015
P=N/A, N=100, Recruiting, Sponsor: University of Colorado, Denver
Active, not recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial completion, Trial primary completion date: Endocervical Evaluation With the Curette Versus Cytobrush for the Diagnosis of Dysplasia of the Uterine Cervix (clinicaltrials.gov) - May 28, 2015
P=N/A, N=180, Completed, Sponsor: University Hospital, Geneva
Not yet recruiting --> Recruiting Enrolling by invitation --> Completed | Trial primary completion date: May 2012 --> Sep 2014